The lame-duck session of Congress offers the opportunity for advocates to finally convince lawmakers to repeal a federal tax on medical devices.

Published in Health Care

In 2014, the narcotic overdose treatment Naloxone cost $690. Today, the same drug sells for $4,500.

Published in Health Care

MATTAWAN — The proposed sale of MPI Research Inc. to Charles River Laboratories International Inc. for $800 million would end local ownership for a company that’s one of the largest employers in the greater Kalamazoo area.

Published in Breaking News

GRAND RAPIDS — In the three years since Peter Jones moved from Los Angeles to Grand Rapids, he’s helped to more than double the amount of federal research funding that Van Andel Institute receives.

Published in Breaking News

KALAMAZOO — A major expansion by Stryker Corp. could provide a welcome shot in the arm for Southwest Michigan’s life sciences sector. 

Published in Manufacturing

While West Michigan may lack the depth of resources and talent that some regions of the country possess when it comes to the medical device industry, it may have one key advantage: the affordability of its contract manufacturing. 

Published in Manufacturing

 

The availability of scientific and executive management talent and the access to later-stage investment capital remain major issues for Michigan’s life sciences industry.

Published in Health Care

The restoration of an angel tax credit in Michigan looks doubtful before the present legislative term expires at the end of the year.

Published in Finance

state lawmaker wants to restore an angel investment tax credit in Michigan as a way to create a larger pool of prospective investors in startup companies.

Published in Finance

Michigan’s life sciences industry recorded growth in most sectors between 2012 and 2014 in both jobs and the number of businesses, according to a report from a national trade group.

Published in Health Care
Page 1 of 2